Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk
- PMID: 34891159
- DOI: 10.1093/eurheartj/ehab809
Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk
Retraction in
-
Retraction of: Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk.Eur Heart J. 2025 Apr 15;46(15):1456. doi: 10.1093/eurheartj/ehaf081. Eur Heart J. 2025. PMID: 39938556 No abstract available.
Expression of concern in
-
Expression of Concern: Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk.Eur Heart J. 2024 Jul 9;45(26):2305. doi: 10.1093/eurheartj/ehae282. Eur Heart J. 2024. Retraction in: Eur Heart J. 2025 Apr 15;46(15):1456. doi: 10.1093/eurheartj/ehaf081. PMID: 38820075 Retracted. No abstract available.
Abstract
Aims: Low vitamin D status is associated with a higher risk for cardiovascular diseases (CVDs). Although most existing linear Mendelian randomization (MR) studies reported a null effect of vitamin D on CVD risk, a non-linear effect cannot be excluded. Our aim was to apply the non-linear MR design to investigate the association of serum 25-hydroxyvitamin D [25(OH)D] concentration with CVD risk.
Methods and results: The non-linear MR analysis was conducted in the UK Biobank with 44 519 CVD cases and 251 269 controls. Blood pressure (BP) and cardiac-imaging-derived phenotypes were included as secondary outcomes. Serum 25(OH)D concentration was instrumented using 35 confirmed genome-wide significant variants.We also estimated the potential reduction in CVD incidence attributable to correction of low vitamin D status. There was a L-shaped association between genetically predicted serum 25(OH)D and CVD risk (Pnon-linear = 0.007), where CVD risk initially decreased steeply with increasing concentrations and levelled off at around 50 nmol/L. A similar association was seen for systolic (Pnon-linear = 0.03) and diastolic (Pnon-linear = 0.07) BP. No evidence of association was seen for cardiac-imaging phenotypes (P = 0.05 for all). Correction of serum 25(OH)D level below 50 nmol/L was predicted to result in a 4.4% reduction in CVD incidence (95% confidence interval: 1.8- 7.3%).
Conclusion: Vitamin D deficiency can increase the risk of CVD. Burden of CVD could be reduced by population-wide correction of low vitamin D status.
Keywords: Cardiac-imaging phenotypes; Cardiovascular diseases; Diastolic blood pressure; Non-linear Mendelian randomization; Serum 25-hydroxyvitamin Dconcentration; Systolic blood pressure; Vitamin D.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
Comment in
-
Genetic evidence for vitamin D and cardiovascular disease: choice of variants is critical.Eur Heart J. 2022 May 7;43(18):1740-1742. doi: 10.1093/eurheartj/ehab870. Eur Heart J. 2022. PMID: 34972215 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
